Macular disease

Nova Eye Medical has announced positive five-year follow-up data from a sub-study analysis of the multi-centre LEAD trial for its...

The Australian government spent more than $610 million on anti-VEGF treatments during the past year, with aflibercept (Eylea) leapfrogging a...

A clinical trial is under way in Australia for a novel eye drop treatment for retinal vascular diseases that could...

Researchers from the Centre for Eye Research Australia and University of Melbourne have developed a world-first survey to gather the...

An Australian researcher has contributed to a new study demonstrating that lower carbohydrate consumption can potentially put type 2 diabetes...

Swiss drug giant Roche is poised to pursue regulatory clearance for its new faricimab antibody for diabetic macular edema (DME)...

Despite vehement opposition from ophthalmologists, the MBS Taskforce has forged ahead with plans to cut the rebate for intravitreal injections...

Novartis has announced positive findings from its the Phase 3 trial assessing the efficacy and safety of Beovu (brolucizumab) to...

Retina Australia has awarded a total of $160,000 in study grants to some of the biggest names in Australian retinal...

Professor Robyn Guymer has led an expert panel to update RANZCO’s Referral Pathway for Age-Related Macular Degeneration (AMD) Management, which...